NASDAQ:RLYB

Rallybio Stock Faces a $50 Million Test as Traders Weigh What Comes Next

Rallybio Stock Faces a $50 Million Test as Traders Weigh What Comes Next

Rallybio shares last traded at $14.52, holding steady after receiving a $50 million break fee from Candid Therapeutics’ canceled merger. The payment now accounts for about two-thirds of Rallybio’s equity value. No new company news has moved the stock, and its lead drug candidate remains far from approval. Trading volume Thursday was 21,282 shares.
May 29, 2026

Stock Market Today

  • London Stock Market Rallies as Oil Prices Dip and Ocado Gains Attention
    May 29, 2026, 8:20 AM EDT. London's stock market rallied as oil prices eased, relieving some pressure on energy-sensitive sectors. The FTSE 100 index climbed, boosted by lower crude costs which often reduce inflation fears. Investors shifted focus to Ocado, the online grocery retailer, which saw increased trading activity and share price gains amid renewed investor interest. The market's positive momentum highlights a cautious optimism amid fluctuating commodity prices. Analysts note that although oil price easing provides short-term support, broader economic concerns remain. Ocado's performance underscores the growing market appetite for e-commerce and technology-linked stocks in the UK.